BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: El Dika I, Abou-Alfa GK. The role (if any) of chemotherapy in hepatocellular carcinoma. Lancet Gastroenterol Hepatol 2017;2:387-9. [PMID: 28497748 DOI: 10.1016/S2468-1253(17)30104-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Chen M, Wu L, Tu J, Zhao Z, Fan X, Mao J, Weng Q, Wu X, Huang L, Xu M, Ji J. miR-590-5p suppresses hepatocellular carcinoma chemoresistance by targeting YAP1 expression. EBioMedicine 2018;35:142-54. [PMID: 30111512 DOI: 10.1016/j.ebiom.2018.08.010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 31] [Article Influence: 6.3] [Reference Citation Analysis]
2 Ma X, Wang J, Zhuang J, Ma X, Zheng N, Song Y, Xia W. P4HB modulates epithelial-mesenchymal transition and the β-catenin/Snail pathway influencing chemoresistance in liver cancer cells. Oncol Lett 2020;20:257-65. [PMID: 32565952 DOI: 10.3892/ol.2020.11569] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
3 Wu S, Zhang D, Yu J, Dou J, Li X, Mu M, Liang P. Chemotherapeutic Nanoparticle-Based Liposomes Enhance the Efficiency of Mild Microwave Ablation in Hepatocellular Carcinoma Therapy. Front Pharmacol 2020;11:85. [PMID: 32174827 DOI: 10.3389/fphar.2020.00085] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]